Advertisement
Advertisement

PMVP

PMVP logo

PMV Pharmaceuticals, Inc

1.41
USD
Sponsored
-0.06
-4.08%
Apr 15, 16:00 UTC -4
Closed
exchange

After-Market

1.41

0.00
0.00%

PMVP Earnings Reports

Positive Surprise Ratio

PMVP beat 13 of 21 last estimates.

62%

Next Report

Date of Next Report
May 08, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.41
Implied change from Q4 25 (Revenue/ EPS)
--
/
+20.59%
Implied change from Q1 25 (Revenue/ EPS)
--
/
+20.59%

PMV Pharmaceuticals, Inc earnings per share and revenue

On Mar 06, 2026, PMVP reported earnings of -0.34 USD per share (EPS) for Q4 25, beating the estimate of -0.41 USD, resulting in a 17.70% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -10.00% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.41 USD, with revenue projected to reach -- USD, implying an increase of 20.59% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.07
Surprise
+14.22%
logo
Jupiter Neurosciences, Inc. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.06
Surprise
+6.16%
logo
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-
Actual
-$0.44
Surprise
-
FAQ
For Q4 2025, PMV Pharmaceuticals, Inc reported EPS of -$0.34, beating estimates by 17.7%, and revenue of $0.00, 0% as expectations.
The stock price moved down -10%, changed from $1.80 before the earnings release to $1.62 the day after.
The next earning report is scheduled for May 08, 2026.
Based on 5 analysts, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.41 and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement